Post-Operative Pain - Pipeline Review, H1 2019

Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H1 2019’, provides an overview of the Post-Operative Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Post-Operative Pain

- The report reviews pipeline therapeutics for Post-Operative Pain by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Post-Operative Pain therapeutics and enlists all their major and minor projects

- The report assesses Post-Operative Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Post-Operative Pain

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Post-Operative Pain

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Post-Operative Pain pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Abide Therapeutics Inc

AcelRx Pharmaceuticals Inc

Adynxx Inc

AngioChem Inc

Aoxing Pharmaceutical Company Inc

Apsen Farmaceutica SA

Cadila Healthcare Ltd

Camurus AB

Cara Therapeutics Inc ...

Abide Therapeutics Inc

AcelRx Pharmaceuticals Inc

Adynxx Inc

AngioChem Inc

Aoxing Pharmaceutical Company Inc

Apsen Farmaceutica SA

Cadila Healthcare Ltd

Camurus AB

Cara Therapeutics Inc

Cellix Bio Pvt Ltd

CerSci Therapeutics Inc

Cytogel Pharma LLC

Dompe Farmaceutici SpA

DURECT Corp

Esteve Pharmaceuticals SA

Eupraxia Pharmaceuticals Inc

EyeGate Pharmaceuticals Inc

Fujimoto Pharmaceutical Corp

Grunenthal GmbH

Heron Therapeutics Inc

Immupharma Plc

Innocoll AG

Insys Therapeutics Inc

Ionis Pharmaceuticals Inc

iX Biopharma Ltd

Jiangsu Hengrui Medicine Co Ltd

Liquidia Technologies Inc

Lumosa Therapeutics Co Ltd

MedinCell SA

Medtronic Plc

Mundipharma International Ltd

Neumentum Inc

Novartis AG

Ocular Therapeutix Inc

Pacira Pharmaceuticals Inc

PainReform Ltd

Pharmaleads SA

PhytoHealth Corp

PixarBio Corp

PolyPid Ltd

RaQualia Pharma Inc

Recro Pharma Inc

Rottapharm Biotech Srl

Serina Therapeutics Inc

Shijiazhuang Yiling Pharmaceutical Co Ltd

Sichuan Kelun Pharmaceutical Co Ltd

SiteOne Therapeutics Inc

SteadyMed Therapeutics Inc

Taiwan Liposome Co Ltd

Teikoku Pharma USA Inc

Trevena Inc

Xigen SA

YiChang Humanwell Pharmaceutical Co Ltd

Table of Contents

Table of Contents

Introduction

Post-Operative Pain – Overview

Post-Operative Pain – Therapeutics Development

Post-Operative Pain – Therapeutics Assessment

Post-Operative Pain – Companies Involved in Therapeutics ...

Table of Contents

Introduction

Post-Operative Pain – Overview

Post-Operative Pain – Therapeutics Development

Post-Operative Pain – Therapeutics Assessment

Post-Operative Pain – Companies Involved in Therapeutics Development

Post-Operative Pain – Drug Profiles

Post-Operative Pain – Dormant Projects

Post-Operative Pain – Discontinued Products

Post-Operative Pain – Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Post-Operative Pain, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products ...

List of Tables

Number of Products under Development for Post-Operative Pain, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Products under Development by Companies, H1 2019

Products under Development by Universities/Institutes, H1 2019

Number of Products by Stage and Target, H1 2019

Number of Products by Stage and Mechanism of Action, H1 2019

Number of Products by Stage and Route of Administration, H1 2019

Number of Products by Stage and Molecule Type, H1 2019

Post-Operative Pain – Pipeline by Abide Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by AcelRx Pharmaceuticals Inc, H1 2019

Post-Operative Pain – Pipeline by Adynxx Inc, H1 2019

Post-Operative Pain – Pipeline by AngioChem Inc, H1 2019

Post-Operative Pain – Pipeline by Aoxing Pharmaceutical Company Inc, H1 2019

Post-Operative Pain – Pipeline by Apsen Farmaceutica SA, H1 2019

Post-Operative Pain – Pipeline by Cadila Healthcare Ltd, H1 2019

Post-Operative Pain – Pipeline by Camurus AB, H1 2019

Post-Operative Pain – Pipeline by Cara Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by Cellix Bio Pvt Ltd, H1 2019

Post-Operative Pain – Pipeline by CerSci Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by Cytogel Pharma LLC, H1 2019

Post-Operative Pain – Pipeline by Dompe Farmaceutici SpA, H1 2019

Post-Operative Pain – Pipeline by DURECT Corp, H1 2019

Post-Operative Pain – Pipeline by Esteve Pharmaceuticals SA, H1 2019

Post-Operative Pain – Pipeline by Eupraxia Pharmaceuticals Inc, H1 2019

Post-Operative Pain – Pipeline by EyeGate Pharmaceuticals Inc, H1 2019

Post-Operative Pain – Pipeline by Fujimoto Pharmaceutical Corp, H1 2019

Post-Operative Pain – Pipeline by Grunenthal GmbH, H1 2019

Post-Operative Pain – Pipeline by Heron Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by Immupharma Plc, H1 2019

Post-Operative Pain – Pipeline by Innocoll AG, H1 2019

Post-Operative Pain – Pipeline by Insys Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by Ionis Pharmaceuticals Inc, H1 2019

Post-Operative Pain – Pipeline by iX Biopharma Ltd, H1 2019

Post-Operative Pain – Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2019

Post-Operative Pain – Pipeline by Liquidia Technologies Inc, H1 2019

Post-Operative Pain – Pipeline by Lumosa Therapeutics Co Ltd, H1 2019

Post-Operative Pain – Pipeline by MedinCell SA, H1 2019

Post-Operative Pain – Pipeline by Medtronic Plc, H1 2019

Post-Operative Pain – Pipeline by Mundipharma International Ltd, H1 2019

Post-Operative Pain – Pipeline by Neumentum Inc, H1 2019

Post-Operative Pain – Pipeline by Novartis AG, H1 2019

Post-Operative Pain – Pipeline by Ocular Therapeutix Inc, H1 2019

Post-Operative Pain – Pipeline by Pacira Pharmaceuticals Inc, H1 2019

Post-Operative Pain – Pipeline by PainReform Ltd, H1 2019

Post-Operative Pain – Pipeline by Pharmaleads SA, H1 2019

Post-Operative Pain – Pipeline by PhytoHealth Corp, H1 2019

Post-Operative Pain – Pipeline by PixarBio Corp, H1 2019

Post-Operative Pain – Pipeline by PolyPid Ltd, H1 2019

Post-Operative Pain – Pipeline by RaQualia Pharma Inc, H1 2019

Post-Operative Pain – Pipeline by Recro Pharma Inc, H1 2019

Post-Operative Pain – Pipeline by Rottapharm Biotech Srl, H1 2019

Post-Operative Pain – Pipeline by Serina Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by Shijiazhuang Yiling Pharmaceutical Co Ltd, H1 2019

Post-Operative Pain – Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H1 2019

Post-Operative Pain – Pipeline by SiteOne Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by SteadyMed Therapeutics Inc, H1 2019

Post-Operative Pain – Pipeline by Taiwan Liposome Co Ltd, H1 2019

Post-Operative Pain – Pipeline by Teikoku Pharma USA Inc, H1 2019

List of Figures

List of Figures

Number of Products under Development for Post-Operative Pain, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products ...

List of Figures

Number of Products under Development for Post-Operative Pain, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Number of Products by Top 10 Targets, H1 2019

Number of Products by Stage and Top 10 Targets, H1 2019

Number of Products by Top 10 Mechanism of Actions, H1 2019

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019

Number of Products by Top 10 Routes of Administration, H1 2019

Number of Products by Stage and Top 10 Routes of Administration, H1 2019

Number of Products by Molecule Types, H1 2019

Number of Products by Stage and Molecule Types, H1 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports